DNTH · Forms 3, 4, 5
Insider trades at Dianthus Therapeutics, Inc. /DE/
6 insiders sold $26.1M of Dianthus Therapeutics, Inc. /DE/ stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Dianthus Therapeutics, Inc. /DE/ (DNTH) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Edward Carr | CHIEF ACCOUNTING OFFICER | Option exercise | 20,000 | $17.88 | $358K | Form 4 | |
| Edward Carr | CHIEF ACCOUNTING OFFICER | Sell (10b5-1 plan) | 7,928 | $100.43 | $796K | Form 4 | |
| Edward Carr | CHIEF ACCOUNTING OFFICER | Sell (10b5-1 plan) | 6,771 | $101.37 | $686K | Form 4 | |
| Edward Carr | CHIEF ACCOUNTING OFFICER | Sell (10b5-1 plan) | 3,501 | $102.39 | $358K | Form 4 | |
| Edward Carr | CHIEF ACCOUNTING OFFICER | Sell (10b5-1 plan) | 1,100 | $103.20 | $114K | Form 4 | |
| Edward Carr | CHIEF ACCOUNTING OFFICER | Sell (10b5-1 plan) | 700 | $104.39 | $73K | Form 4 | |
| Simrat Randhawa | EVP, Head of R&D | Option exercise | 7,500 | $17.88 | $134K | Form 4 | |
| Simrat Randhawa | EVP, Head of R&D | Option exercise | 6,249 | $21.77 | $136K | Form 4 | |
| Simrat Randhawa | EVP, Head of R&D | Option exercise | 9,375 | $22.07 | $207K | Form 4 | |
| Simrat Randhawa | EVP, Head of R&D | Sell (10b5-1 plan) | 2,600 | $105.19 | $273K | Form 4 | |
| Simrat Randhawa | EVP, Head of R&D | Sell (10b5-1 plan) | 7,215 | $106.25 | $767K | Form 4 | |
| Simrat Randhawa | EVP, Head of R&D | Sell (10b5-1 plan) | 13,309 | $106.74 | $1.4M | Form 4 | |
| Simon Read | Director | Option exercise | 2,778 | $18.36 | $51K | Form 4 | |
| Simon Read | Director | Sell (10b5-1 plan) | 2,778 | $117.55 | $327K | Form 4 | |
| Adam M Veness | SVP, General Counsel and Sec. | Option exercise | 15,000 | $18.17 | $273K | Form 4 | |
| Anne McGeorge | Director | Option exercise | 1,250 | $19.36 | $24K | Form 4 | |
| Anne McGeorge | Director | Option exercise | 6,500 | $11.20 | $73K | Form 4 | |
| Anne McGeorge | Director | Sell (10b5-1 plan) | 1,450 | $107.58 | $156K | Form 4 | |
| Anne McGeorge | Director | Sell (10b5-1 plan) | 2,800 | $108.38 | $303K | Form 4 | |
| Anne McGeorge | Director | Sell (10b5-1 plan) | 1,800 | $109.30 | $197K | Form 4 | |
| Anne McGeorge | Director | Sell (10b5-1 plan) | 1,000 | $110.64 | $111K | Form 4 | |
| Anne McGeorge | Director | Sell (10b5-1 plan) | 700 | $111.41 | $78K | Form 4 | |
| Simon Read | Director | Option exercise | 2,777 | $18.36 | $51K | Form 4 | |
| Simon Read | Director | Sell (10b5-1 plan) | 70 | $107.11 | $7K | Form 4 | |
| Simon Read | Director | Sell (10b5-1 plan) | 737 | $108.17 | $80K | Form 4 | |
| Simon Read | Director | Sell (10b5-1 plan) | 831 | $108.95 | $91K | Form 4 | |
| Simon Read | Director | Sell (10b5-1 plan) | 272 | $109.96 | $30K | Form 4 | |
| Simon Read | Director | Sell (10b5-1 plan) | 470 | $111.05 | $52K | Form 4 | |
| Simon Read | Director | Sell (10b5-1 plan) | 397 | $111.77 | $44K | Form 4 | |
| Adam M Veness | SVP, General Counsel and Sec. | Option exercise | 16,167 | $17.88 | $289K | Form 4 | |
| Adam M Veness | SVP, General Counsel and Sec. | Sell (10b5-1 plan) | 16,167 | $110.38 | $1.8M | Form 4 | |
| Adam M Veness | SVP, General Counsel and Sec. | Option exercise | 3,833 | $17.88 | $69K | Form 4 | |
| Adam M Veness | SVP, General Counsel and Sec. | Sell (10b5-1 plan) | 3,217 | $110.61 | $356K | Form 4 | |
| Adam M Veness | SVP, General Counsel and Sec. | Sell (10b5-1 plan) | 616 | $111.18 | $68K | Form 4 | |
| Marino Garcia | CEO AND PRESIDENT | Option exercise | 40,000 | $8.44 | $338K | Form 4 | |
| Marino Garcia | CEO AND PRESIDENT | Option exercise | 126,000 | $8.44 | $1.1M | Form 4 | |
| Marino Garcia | CEO AND PRESIDENT | Sell (10b5-1 plan) | 10,384 | $107.49 | $1.1M | Form 4 | |
| Marino Garcia | CEO AND PRESIDENT | Sell (10b5-1 plan) | 23,907 | $108.05 | $2.6M | Form 4 | |
| Marino Garcia | CEO AND PRESIDENT | Sell (10b5-1 plan) | 2,373 | $109.10 | $259K | Form 4 | |
| Marino Garcia | CEO AND PRESIDENT | Sell (10b5-1 plan) | 2,536 | $110.02 | $279K | Form 4 | |
| Marino Garcia | CEO AND PRESIDENT | Sell (10b5-1 plan) | 800 | $110.76 | $89K | Form 4 | |
| Marino Garcia | CEO AND PRESIDENT | Sell (10b5-1 plan) | 104,091 | $107.96 | $11.2M | Form 4 | |
| Marino Garcia | CEO AND PRESIDENT | Sell (10b5-1 plan) | 21,909 | $108.72 | $2.4M | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.